4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000950170-24-084761
Chief Executive Officer sold 22,528 shares at $6.47 ($145,815)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tak Paul Peter Chief Executive Officer | 2024-07-17 | Sale | −22,528 | $6.47 | $145,815 | 330,735 | D |
| Open-market sales · 22,528 sh · avg $6.47 · $145,815 | |||||||
Loading xslF345X05/ownership.xml…